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Abstract Low voltage-activated T-type calcium channels are
encoded by a family of at least three genes, with additional
diversity created by alternative splicing. This study describes the
cloning of the human brain K1G, which is a novel isoform,
Cav3.1c. Comparison of this sequence to genomic sequences
deposited in the GenBank allowed us to identify the intron/exon
boundaries of the human CACNA1G gene. A full-length cDNA
was constructed, then used to generate a stably-transfected
mammalian cell line. The resulting currents were analyzed for
their voltage- and time-dependent properties. These properties
identify this gene as encoding a T-type Ca2+ channel.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Voltage-gated calcium channels are formed by large K1
subunits that contain the voltage sensing and pore forming
regions. Ten K1 genes have been cloned [1]. Based on similar-
ities in their deduced amino acid sequences, these K1 subunits
can be classi¢ed as belonging to one of three groups: Cav1, or
L-type family, is composed of K1S, K1C, K1D and K1F; the
Cav2 family is composed of K1A, K1B and K1E; and the Cav3
or T-type family (CavT), is composed of K1G, K1H and K1I
[1]. These channels play a central role in modulating intra-
cellular calcium concentrations, and hence control muscle
contractility, gene expression, and secretion of neurotransmit-
ters and hormones [2].
In this study, we cloned a novel splice variant of the human
K1G gene, CACNA1G, which we call Cav3.1c. The full-length
cDNA was transfected into human embryonic kidney cells
(HEK-293), and a stably-transfected cell line was isolated.
The basic electrophysiological properties of the resulting T
currents were characterized. We then took advantage of the
well-isolated currents to study the dose-dependent block of T-
type channels by nickel.
2. Materials and methods
2.1. Cloning of human K1G
The full-length K1G cDNA was cloned by multiple screens of
cDNA libraries (Clontech, Palo Alto, CA, USA) from either human
thalamus or cerebellum. Screening was done by ¢lter hybridization
according to the manufacturer’s protocol. The cDNA probes were
synthesized using [K-32P]dCTP and a labeling kit (Amersham Phar-
macia Biotech, Piscataway, NJ, USA). The full-length cDNA (hK1G)
was assembled from the overlapping cDNA fragments shown sche-
matically in Fig. 1A. The ‘hg¢nPCR’ fragment was synthesized by
RNA-PCR using human brain mRNA (Clontech) and the following
PCR primers: forward, 5P-G-A-C-A-A-C-A-T-C-G-G-C-T-A-C-G-C-
C-T-G-G-A-T-C-3P ; reverse, 5P-G-G-G-G-G-C-C-C-C-G-G-A-G-A-
G-G-G-C-A-G-G-3P. This resulted in ‘hg¢nPCR’ (1012^1638). The
5P clone ‘Fre12u’ (3216^1342) was ligated to the SalI site of
‘hg¢nPCR’. This was connected to clone ‘C5’ (cerebellum, 1473^
2695) at the S¢I site, then to clone ‘C7’ (cerebellum, 2360^3713) at
the NsiI site, then to the 3P clone ‘15-2’ (thalamus, 3400^7187) at the
XhoI site. The fully-assembled cDNA (3216^6949) was then cloned
into the KpnI site of the transfection vector pcDNA3 (Invitrogen).
The full-length cDNA was sequenced on both strands.
2.2. Electrophysiological analysis of HEK-293 transfected cells
Preparation of a stably-transfected cell line expressing the rat K1G
(Cav3.1a) was described previously [3]. Similar methods were used to
generate a cell line expressing the human K1G ‘hK1G-39’. The meth-
ods used to prepare the cells for electrophysiological studies have been
described previously [3]. The recording solution contained the follow-
ing (in mM): 10 BaCl2, 155 tetraethylammonium chloride, 6 CsCl,
and 10 HEPES, pH adjusted to 7.4 with tetraethylammonium hydrox-
ide. The standard internal pipette solution contained the following (in
mM): 65 CsCl, 75 CsMeSO4, 1 MgCl2, 4 MgATP, 1 EGTA, and 10
HEPES, pH adjusted to 7.3 with CsOH.
Whole-cell currents were recorded from ruptured patches using an
Axopatch 200B ampli¢er, Digidata 1200 A/D converter, and
pCLAMP 7.0 software (Axon Instruments, Foster City, CA, USA).
Data were ¢ltered at 5 kHz and digitized at 10 kHz, except for tail
current measurements, which were digitized at 50 kHz. Pipettes were
made from TW-150-6 capillary tubing. The pipette resistance was
typically 1.5^2.0 M6. Series resistances and cell capacitance were
compensated at least 80%. The average cell capacitance was V25
pF. All experiments were performed at room temperature with con-
stant perfusion of the bath (1^3 ml/min). Leak currents were minimal,
therefore online leak subtraction was not used. A 100 mM NiCl2
stock solution was prepared in deionized water. Peak currents and
exponential ¢ts to currents were determined using Clamp¢t software
(Axon Instruments). Fits and graphs of the data were done with Prism
(GraphPad, San Diego, CA, USA). Average data are presented as
mean þ S.E.M.
3. Results
Cloning of the T-type Ca2 channel family began with the
identi¢cation of a human EST clone as belonging to a novel
ion channel [4]. Due to the di⁄culties in cloning an 8.5 kb
cDNA from a single library and in obtaining undegraded
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human RNA, we ¢rst cloned the rat K1G. We now report the
cloning of human K1G cDNAs and construction of a full-
length cDNA from ¢ve overlapping clones (Fig. 1A). The
sequence contains an open reading frame that would encode
a 251 kDa protein composed of 2296 amino acids (GenBank
No. AF190860). This deduced amino acid sequence is 93%
identical to the rat and mouse K1G sequences (GenBank
Nos. AF027984, AJ012569, respectively), with most substitu-
tions occurring in the carboxyl-terminus. In contrast, the hu-
man K1G is only V60% identical to either the human K1H or
K1I sequences (GenBank Nos. AF073931, AF129133, respec-
tively). The regions of highest identity are the putative mem-
brane spanning regions, where the three human genes are
approximately 90% identical.
Preliminary reports have described the existence of splice
variants for the CACNA1G gene occurring in two locations,
one immediately after the sixth transmembrane region of the
second repeat, IIS6 [5], and the second in the middle of the
III-IV linker [5,6]. The human genomic sequence (GenBank
No. AC005921) was sequenced by the MIT Center for Ge-
nome Research (Birren, B., Linton, L., Nusbaum, C. and
Lander, E., unpublished). Comparison of the cloned cDNAs
to this genomic sequence allowed the determination of the
intron/exon boundaries (Fig. 1B) and resolution of the mech-
anisms of alternative splicing. Splicing of the III-IV linker is
the result of two processes. One, an alternative 3P splice donor
site is used at the end of an exon leading the presence or
absence of seven amino acids (SKEKQMA). Two, this exon
is either joined to a small exon encoding 18 amino acids
(DLMLDDVIASGSSASAAS) or not. The combination of
these two events produces four gene products. We propose
a nomenclature where the original rat clone is called
Cav3.1a, which contains the ¢rst but not the second sequence
(+,3). A sequence lacking both regions is called Cav3.1b
(3,3 ; e.g. GenBank No. AF126965). The present sequence
contains both regions (Cav3.1c). A sequence lacking the ¢rst,
but containing the second region is called Cav3.1d (e.g. Gen-
Bank No. AF125161).
The diversity after IIS6 is caused by insertion (GenBank
No. AB012043) or skipping (present results) of a small exon
that encodes 23 amino acids. Apparently similar splicing oc-
curs in the rodent K1G genes [5,7]. Neither the functional
signi¢cance of this splicing event, nor the correlation with
the III-IV linker variations, has been reported. Two cDNAs
for this region were cloned from the cerebellar library (C4 and
C7), and neither contained this insert.
Functional expression of human Cav3.1c was studied in a
stably-transfected HEK-293 cell line. Fig. 2A shows a family
of Ba2 currents elicited by depolarizations in 10 mV incre-
ments from a holding potential of 390 mV. The character-
istics of the generated current are similar to native T currents
studied in isolation. Activation and inactivation kinetics are
faster at more depolarized voltages, producing the typical
pattern of criss-crossing traces observed in most recordings
of native T-type Ca2 currents [8^10]. The peak current in
each episode was measured, averaged, then plotted as a func-
tion of the test potential to derive the current-voltage (I-V)
relationship (Fig. 2B). Current started to be detectable at 360
mV, peaked near 320 mV, and reversed at a membrane po-
tential around +50 mV.
There are several procedures to measure the activation of
T-type Ca2 channels, each with its limitations. In this study,
Fig. 1. Deduced amino acid sequence of human brain Cav3.1c. A:
Schematic diagram of the human Cav3.1c cDNA. A full-length
cDNA was constructed from the ¢ve fragments using the indicated
restriction enzyme sites. B: The deduced amino acid sequence of the
human Cav3.1c was compared to the rat Cav3.1a [4], and amino
acid di¡erences are shown in lower case letters. Transmembrane re-
gions and exon boundaries (8) are marked above the sequence.
Splice variation leads to the appearance of either 23 amino acids in
the II-III loop, or 18 amino acids in the III-IV interdomain loop
(bold italics).
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we used the method described by Serrano et al. [11] where the
I-V data are divided by the instantaneous I-V. The protocol
for obtaining the instantaneous I-V relationship included a
short 2 ms pulse to +60 mV (to activate all the available
channels and to minimize the inactivation), followed by a
test pulse to di¡erent voltages ranging from 3120 to +50
mV (inset, Fig. 3B). Because the same number of channels
is expected to open during the +60 mV pulse, the only vari-
able during the test pulses is the voltage-dependence of cur-
rent £ow through the open channel. The result shows a non-
linear I-V relationship (Fig. 2C), suggesting complex interac-
tions between permeant ions and the pore of the channel. The
voltage-dependence of the activation of human K1G channels
was ¢nally obtained by dividing the I-V curve (Fig. 2B) by the
instantaneous I-V curve (Fig. 2C). The result is shown in Fig.
2D. Each point of this curve is proportional to the number of
channels open at the time of peak current at the respective
voltage. Experimental data were ¢tted with a single Boltz-
mann function. The half-maximal activation for human K1G
was reached at 326 mV, with a slope factor of 10.3.
The activation and inactivation kinetics of the human
Cav3.1c channels were studied using 100 ms pulses to di¡erent
potentials. The current recordings were ¢tted with two expo-
nentials and the results are shown in Fig. 3A. The rapid acti-
vation of the K1G channels was strongly voltage-dependent,
with time constants ranging from 5.8 þ 0.8 to 0.9 þ 0.1 ms for
membrane potentials between 350 and 0 mV (n = 16). At
more depolarized potentials (+10 to +40 mV), the current
activates with a stable time constant around 0.9 ms. Current
decay, or inactivation, was relatively slow at more negative
voltages (350 to 320 mV, d= 52.0 þ 6.3 and 10.7 þ 1.0 ms,
respectively) and varied very little at voltages between 310
to +40 mV (9.8 þ 0.8 at +10 mV to 12.3 þ 1.8 at +40 mV).
We also studied the time course of deactivation produced
by the closing of human Cav3.1c channels after a short depo-
larizing pulse. The tail currents recorded with this protocol
(Fig. 3B inset) were ¢tted with a single exponential and the
time constants obtained are plotted in Fig. 3B. At very neg-
ative potentials, the closing of the channels was very sensitive
to voltage changes. The time constant changed exponentially
with voltage (e-fold for 33.8 þ 1.9 mV, n = 8) for repolarization
potentials between 3120 and 350 mV. However, tail currents
generated by repolarizations more positive than 350 mV
showed little change in the time constant (from 8.1 þ 0.2 at
340 mV to 10.1 þ 0.9 at +40 mV). This result suggests that
human K1G channel closing is voltage-dependent predomi-
nantly at extreme negative voltages.
The steady-state inactivation of human Cav3.1c channels
was studied by applying 30 s prepulses before a test potential
to 320 mV to measure channel availability. The results are
plotted in Fig. 2D and the inset shows representative current
traces. The averaged data were ¢tted with a Boltzmann func-
tion with the following values: V50 =368.9 mV and k = 4.6.
Similar results were obtained with rat Cav3.1a channels,
whose V50 was just 2 mV more negative than the human
Cav3.1c channels [3]. T-type Ca2 channels have been pro-
posed to lead to spontaneous oscillations of the resting mem-
brane potential (reviewed in [12]). To function in this manner,
there must be membrane potentials where channels can open
but are not completely inactivated. This property has also
been called a window current, and is usually de¢ned as the
overlap region between the activation and steady-state inacti-
vation curves. Using ¢ts to the data of Fig. 2D, we calculated
that 0.2% of channels (percentage of channels activated multi-
plied by percentage of channels available to activate) may
open at 355 mV, and this amount decreases to 0.1% at
350 mV.
The time courses and voltage-dependence of recovery from
inactivation, or deinactivation, of human Cav3.1c channels
were investigated using the voltage protocol illustrated in
Fig. 3C. Recovery from inactivation at 3100 and 390 mV
was basically complete and showed the same time course (time
constants of 65 þ 3 and 64 þ 3 ms, respectively). Recovery was
incomplete at 380 and 370 mV, and much slower (380,
d= 79 þ 4; 370 mV, d= 121 þ 4 ms).
The dose-dependence of NiCl2 block was also determined.
Nickel produced a fast block that was readily reversed upon
washout. Increasing concentrations were assayed without
Fig. 2. Current-voltage (I-V) relation for human Cav3.1c channels.
A: Representative whole-cell Ba2 currents obtained from a stably-
transfected HEK-293 cell at 10 s intervals in response to 100 ms de-
polarizing pulses of 10 mV steps from a holding potential of 390
mV. B: I-V relationships averaged from 13 cells. Data points
(mean þ S.E.M.) show peak current at each potential. C: Instantane-
ous I-V relation was measured using tail currents. Channels were
activated by a 2 ms depolarizing pulse to +60 mV, and the ampli-
tude of the tail current was measured after repolarization to di¡er-
ent potentials. Recordings were ¢ltered at 5 kHz and digitally
sampled every 20 Ws. Averaged tail current amplitudes (n = 7) are
plotted vs. repolarization potential. Currents were measured at the
peak of the tail current, which varied from 0.35 to 0.55 ms. D: Ac-
tivation curve was obtained by the following ratio: the peak current
recorded using the I-V protocol (B) was divided by the instantane-
ous current recorded during repolarization from a 2 ms step to +60
mV (C). Experimental data points (b, n = 7) were ¢tted with a
Boltzmann function (smooth curve): I = Imax/(1+exp [3(V3V50)/k]),
where I is the peak current, Imax is the saturating value of I at posi-
tive membrane potentials, V50 is the voltage where one half of the
channels are in the open conformation, and k is the slope factor
(mV). Also shown is the voltage-dependence of steady-state inactiva-
tion. Human Cav3.1c currents were activated by voltage steps to
320 mV after 30 s conditioning pulses to potentials between 390
and 340 mV. Data points (a, n = 11) were ¢tted with a Boltzmann
function (smooth curve). Inset: representative currents at 320 mV.
FEBS 23182 14-1-00
L.L. Cribbs et al./FEBS Letters 466 (2000) 54^5856
washout as described previously [13]. The IC50 was 0.15 þ 0.02
mM (n = 4).
4. Discussion
The present study reports the cloning of a novel isoform of
K1G from human brain, which we call Cav3.1c. A full-length
cDNA was constructed, then stably-transfected into HEK-293
cells. The resulting channels were analyzed for their time- and
voltage-dependent properties.
The CACNA1G gene is alternatively spliced in at least two
locations leading to changes in the channel protein. The hu-
man isoform reported herein, Cav3.1c, di¡ers from the one we
originally cloned from rat (Cav3.1a) by having an additional
exon, which leads to the addition of 18 amino acids to the
linker joining repeats III and IV. The III-IV linker has a
number of unusual properties: in both Na and Ca2 chan-
nels, it is always much smaller than the linkers joining the
other repeats, its sequence is well-conserved within a subfam-
ily (e.g. the T-type subfamily composed of K1G, H and I), and
it has been shown to play an important role in the inactiva-
tion of Na channels. In fact, a number of human channelo-
pathies are due to mutations in this linker in Na channels
(reviewed in [14]). Comparison of the kinetics of the human
Cav3.1c to those published for the rat Cav3.1a [3,11] reveals
that the human isoform inactivates and recovers from inacti-
vation V1.5-fold faster. Although it is tempting to speculate
that these di¡erences are due to the III-IV linker splice var-
iation, the contribution of other regions cannot be excluded
(see Fig. 1B for location of amino acid substitutions). We
have started to address this issue using the rat splice variants,
and preliminary results indicate a role of the linker in voltage-
dependent gating, but not on the time-dependence of inacti-
vation [6].
The CACNA1G gene contains an unusual splice site be-
tween exons 1 and 2, where the splice donor site is CCat
and the acceptor is acCT (coding sequence in capitals). A
similar AT-AC splice site has been described in a small subset
of mammalian genes, including those that encode Na chan-
nels [15]. Aberrant splicing of this junction in the Na channel
gene, Scn8a, leads to the induction of motor endplate disease
[16]. It is interesting to speculate that if similar errors occur in
the splicing of CACNA1G, they would lead to loss of channel
function and decreased neuronal excitability.
The following three properties distinguish T-type channels
from high voltage-activated Ca2 channels: activation and
inactivation at lower voltages, faster recovery from inactiva-
tion, and slower deactivation. These di¡erences may provide
insight to their physiological roles. Due to their activation at
negative membrane potentials, and because Ca2 entry causes
depolarization of the membrane, T-type calcium channels are
thought to play an important role as a pacemaker current
[17]. For example, in neurons, T-type channels produce the
low threshold Ca2 spike that is often crowned by a burst of
action potentials mediated by voltage-gated sodium channels
Fig. 3. Kinetic properties of human Cav3.1c channels. A: Activation
and inactivation tau (d) values are plotted as a function of test po-
tential. Data points (n = 16, in both cases) are the time constants
obtained from two exponential ¢ts of currents elicited during the I-
V protocol (Fig. 2A). B: Voltage-dependence of deactivation ki-
netics. Tail currents were recorded using the protocol illustrated in
the inset. For this cell, the series resistance was 3 M6 and Cm = 29
pF, which produced a clamp speed with a time constant of V90
Ws. The peak of the tail currents was reached at 500 Ws. Tail cur-
rents were ¢tted with a simple exponential. Data points show the
average of eight cells. C: Time course of recovery from inactivation
at di¡erent potentials. The inset shows the recovery from inactiva-
tion at 390 mV and the two pulse protocol used. Ba2 currents
were inactivated by a 100 ms pulse to 320 mV, after which the
membrane potential was stepped to 390 mV for periods ranging
from 1 to 1200 ms, at which time a 10 ms activating voltage step to
320 mV was applied. The values are the peak current during the 10
ms pulse, divided by the peak current in the 100 ms pulse (Imax).
The number of cells for each data point varied from seven to 11.
Smooth curves are ¢ts to the data using a one phase exponential as-
sociation equation.
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[12]. T-type channels are also thought to play an important
role in rebound burst ¢ring, which occurs after inhibitory
synaptic potentials (IPSP). The human Cav3.1 channel has
the biophysical properties required to participate in this phe-
nomenon. Speci¢cally, it inactivates over a narrow range of
potentials close to the resting membrane potential of many
neurons, and unlike HVA channels, it recovers very fast.
Both the voltage-dependence and time course of recovery ob-
served with the cloned channel are very similar to the proper-
ties observed for the recovery of the low threshold spike in
native neurons [18]. The physiological signi¢cance of the slow
deactivation of T-type channels is unknown. Notably, there
appears to be more Ca2 £ux through T-type channels after,
than during, an action potential [10]. This property may be
important for coupling these channels to Ca2-dependent K
channels, which would tend to dampen neuronal excitability
[18].
Native T-type currents also di¡er in their pharmacology.
Perhaps the most striking di¡erences noted between T cur-
rents from di¡erent sources is their sensitivity to nickel [12].
Again, studies on the cloned T-type channels provided a mo-
lecular explanation for this heterogeneity, where Ni2 blocks
K1H at V15-fold lower concentrations than either K1G or
K1I [13]. The present study shows that Ni2 blocks the human
Cav3.1c with a similar, albeit slightly higher potency, than its
block of the rat Cav3.1a. We conclude that the sensitivity of
native T currents to Ni2 block provides an assay for the
expression of K1H.
In conclusion, this study reports the cloning of a full-length
sequence of the human K1G and its expression. This sequence
information will allow studies aimed at ¢nding mutations,
which may underlie neurological disorders. The ability to ex-
press the cloned channel at high levels in HEK-293 cells
should also allow the development of a high throughput assay
for novel drugs.
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